Latest Trials
| EudraCT Number: 2004-002453-31 | Sponsor Protocol Number: AC-054-201 | Start Date: 2005-02-15 | ||||||
| Sponsor Name: Actelion Pharmaceuticals Ltd. | ||||||||
| Full Title: A Phase IIb, multi-center, international, double-blind, randomized, placebo-controlled, parallel-group, dose-finding study for the prevention of cerebral vasospasm after aneurysmal subarachnoid hem... | ||||||||
| Medical condition: Prevention of ischaemic complications related to vasospasm in patients with aneurysmal subarachnoid haemorrhage | ||||||||
|
||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | |||||||
| Trial protocol: AT (Completed) SE (Completed) FI (Completed) DE (Completed) IT (Completed) BE (Completed) | ||||||||
| Trial results: View results | ||||||||